on whether restrictions should be imposed on mifepristone, including potentially revoking the generic version's FDA authorization.the company brought the suit to prevent the FDA "from depriving GenBioPro of its constitutional and statutory right to market mifepristone.
لقد قمنا بتلخيص هذا الخبر حتى تتمكن من قراءته بسرعة. إذا كنت مهتمًا بالأخبار، يمكنك قراءة النص الكامل هنا. اقرأ أكثر:
Eugene_Scott Did Ron DeSantis tell you to fire them?
مصر أحدث الأخبار, مصر عناوين
Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.
Abortion-pill rulings could break the FDA, drug companies sayPharmaceutical companies have mobilized against a pair of lower-court rulings restricting access to abortion pills that they contend go far beyond issues of reproductive health and pose a threat to the regulatory foundations of the U.S. drug industry. Big Pharma provides hundreds of millions to the Democrats coffers so they can not be trusted Uh yeah, breaking the government is the overarching goal of these billionaire conservative extremists. We beg you to connect the dots for the public more directly.
مصدر: washingtonpost - 🏆 95. / 72 اقرأ أكثر »